DELCATH SYSTEMS, INC. (NASDAQ:DCTH) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07. Submission of Matters to a Vote of Security Holders
On September7, 2017, Delcath Systems, Inc. (the “Company”), completed its Consent Solicitation in lieu of a Special Meeting of Shareholders. The following is the result of the Consent Solicitation.
| 1. | The proposal to approve an amendment to the Company’s amended and restated certificate of incorporation to effect a reverse stock split of the Company’s common stock, such split to combine a whole number of outstanding shares of our common stock in a range of not less than twenty shares and not more than five hundred shares, in the discretion of the Board, and to grant authorization to the Board to determine, in its sole discretion, whether to implement the reverse stock split, as well as its specific timing, was not approved based upon the following votes, as such proposal received fewer votes in favor than the required majority of the total number of outstanding shares as of the record date required by Delaware law: |
|
VotesFor |
VotesAgainst |
Abstentions |
BrokerNon-Votes |
| 223,439,630 | 154,031,776 | 2,573,539 | -0- |
About DELCATH SYSTEMS, INC. (NASDAQ:DCTH)
Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company’s system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company’s focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver. DELCATH SYSTEMS, INC. (NASDAQ:DCTH) Recent Trading Information
DELCATH SYSTEMS, INC. (NASDAQ:DCTH) closed its last trading session down -0.0241 at 0.0999 with 115,633,619 shares trading hands.